Tag: AfriSummit 2024

Prominent healthcare authorities and industry specialists came together for AfriSummit 2024 during a vital four-day hybrid event dedicated to advancing pharmaceutical and medical device regulations along with interactive training in eCTD and Pharmacovigilance, all to achieve a healthier Africa. 

Set at the Grand Nile Tower, the summit attracted more than 300+ delegates and featured over 80 thought leaders from regulatory, legal, manufacturing, and distribution sectors.

The Egyptian Drug Authority, which was one of the main authorities present at AfriSummit 2024, had Dr. Rasha Ziada, the EDA Chairman Assistant for Professional Development and Capacity Building Affairs, conduct the opening. 

She said: “Achievement of WHO maturity Level 3 is not just a milestone but a responsibility on us, we are responsible in supporting other African countries to reach the same level.” 

Ziada added: “As a regulatory authority, our mission extends beyond safeguarding and overseeing the use of medicines at the national level; it also reaches across Africa.”

Read Also; FG to foster conducive environment for youth – Minister

AfriSummit 2024 highlighted innovative approaches to drug trials and approvals, enriched by workshops like eCTD Training and Pharmacovigilance. 

Dr. Mona Al Moussli, Chairman of AfriSummit, stated: “This year’s AfriSummit was truly extravagant, featuring a remarkable participation of industry leaders. Their insightful presentations underscored the crucial need for harmonization in regulatory practices across Africa, paving the way for a more integrated healthcare landscape.”

Key dignitaries presented their regulatory insights, underscoring the event’s importance in enhancing compliance and improving healthcare standards.

Dr. Najiba Al Shezawy, Co-Chairman of AfriSummit, expressed her gratitude for the participation of various African authorities this year, stating: “We deeply appreciate the contributions of all participating African NRAs, whose insights and engagement are crucial for strengthening our regulatory frameworks and fostering collaboration across the continent.”

Attendees actively engaged in comprehensive roundtable discussions with representatives from key healthcare authorities, fostering an environment of collaboration, which aimed at addressing the regulatory challenges and opportunities facing the pharmaceutical and healthcare sectors.

The summit affirmed its status as the leading annual gathering for the regulatory affairs in pharmaceutical, medical device and healthcare sectors across Africa which are experiencing significant growth.

AfriSummit 2024, an initiative by PRA Consultancy, organized by Hubplus Events in collaboration with Pioneers, will take place from November 3-6, 2024, at the Grand Nile Tower in Cairo, Egypt.

The event brings together stakeholders from the pharmaceutical industry and medical device sector, regulatory bodies and leading solution providers from across Africa and globally.

It aims to drive the unity of healthcare regulations, enhancing access to safe, effective, and high-quality medicines.

Dr. Najiba Al Shezawy, co-founder of AfriSummit, emphasized the importance of regulatory affairs.

He said: “Regulatory harmonization ensures all Africans have access to safe and effective medicines. AfriSummit is key in making significant strides in this area.”

AfriSummit 2024 will feature expert speakers from National regulatory bodies, the pharmaceutical & medical device industries, and global health organizations.

Key topics will include convergence in Regulations, compliance, and innovative pathways. The summit will also offer specialized workshops on Pharmacovigilance and eCTD, equipping attendees with the latest advancements and best practices in the field.

A focal point of the event will be a presentation on the current state of AMA by AUDA-NEPAD followed by valuable sessions and panel discussion, including one on Reliance in post approval changes.

MedDevReg AfriSummit will tackle topics such as “Ensuring Compliance in Africa: MDSAP Audits and GMP Site Inspections for Medical Devices” and “Securing the Supply Chain: Combating Counterfeits in Medical Devices in Africa.”

Read Also: Old Boys host inaugural business summit next month

In a strong show of support for regulatory affairs in Africa, the summit is joined by Haleon as the Titanium Sponsor, Abbott & VISIOTT | TPS as Gold Sponsors, VECTOR Life Sciences as Silver Sponsor, and UniClue for Consultation Services as Associate Sponsor. The Regulatory Affairs Professionals Society (RAPS) serves as the Networking Partner, EVOTEQ as Lunch Sponsor, and EXTEDO as the eCTD AfriSummit Workshop Sponsor.

The African pharmaceutical market is projected to grow at a CAGR of 9.6% from 2020 to 2027, reaching over $70 billion. Harmonizing regulations will be crucial in reducing costs, expediting the introduction of new medicines, and improving healthcare outcomes.

Dr. Mona al Moussli, co-founder of AfriSummit, expresses her excitement for this year’s event, “The 4th edition of AfriSummit in Cairo epitomizes progress and innovation, highlighting the importance of harmonization and reliance in Africa.

This year’s summit will be a catalyst for positive change in the pharmaceutical regulatory landscape across the continent.”